NovaBridge Biosciences Operating Expenses
NovaBridge Biosciences (NBP) reported Operating Expenses of $94.27 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-04-07
- NovaBridge Biosciences operating expenses for the quarter ending 2025-12-31 was $72.90M, a 445.21% increase year-over-year.
- NovaBridge Biosciences operating expenses for the quarter ending 2025-09-30 was $8.99M, a 27.58% decline year-over-year.
- NovaBridge Biosciences operating expenses for the quarter ending 2024-12-31 was $13.37M.
- NovaBridge Biosciences operating expenses for the quarter ending 2024-09-30 was $12.41M.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2025-12-31 | $72.90M derived: 20-F 12 month − 6-K 9 month · filed 2026-04-07 | $81.89M derived: sum of 2 quarters · filed 2026-04-07 | $94.27M 20-F · filed 2026-04-07 | |
| 2025-09-30 | $8.99M derived: 6-K 9 month − 6-K 6 month · filed 2025-12-18 | $21.37M 6-K · filed 2025-12-18 | ||
| 2025-06-30 | $12.38M 6-K · filed 2025-10-06 | |||
| 2024-12-31 | $13.37M derived: 20-F 12 month − 6-K 9 month · filed 2026-04-07 | $25.78M derived: sum of 2 quarters · filed 2026-04-07 | $51.43M 20-F · filed 2026-04-07 | |
| 2024-09-30 | $12.41M derived: 6-K 9 month − 6-K 6 month · filed 2025-12-18 | $38.05M 6-K · filed 2025-12-18 | ||
| 2024-06-30 | $25.64M 6-K · filed 2025-10-06 | |||
| 2023-12-31 | $72.65M 20-F · filed 2026-04-07 | |||
| 2022-12-31 | $51.53M 20-F · filed 2025-04-03 |